HR Execs on the Move

Glaukos

www.glaukos.com

 
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.glaukos.com
  • 229 Avenida Fabricante
    San Clemente, CA USA 92672
  • Phone: 949.481.0510

Executives

Name Title Contact Details
Dana Lombardi
 Sr. Director, Human Resources Profile
Steven Lam
 Senior Quality CMO Specialist Profile
Robert Sanchez
 Sr. Director, R&D Engineering Profile
Gabriella Szekely
 Vice President, Research and Development, Combination Pharmaceutical Products Profile
Desmond Adler
 General Manager and VP of R&D, Corneal Health Profile

Similar Companies

Steth IO

Steth IO is a digital health startup bringing a convergence of technologies -- mobile, cloud, machine learning, and sensors -- to drive down the cost of healthcare.

Ats Medical Services Inc

Ats Medical Services Inc is a Rockford, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EBT Medical

EBT Medical was founded in 2014 with a mission to develop novel neuromodulation technologies which restore control, dignity and independence to those silently suffering from pelvic floor disorders.

LipoScience, Inc.

LipoScience, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

RapidAI

RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus. Based on intelligence gained from over 4 million scans in more than 2000 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible, saving lives, time and money.